Preclinical pharmacokinetic, pharmacodynamic and efficacy relationships of ALG-093702, a liver targeted PD-L1 small molecule inhibitor, in different in vivo models

被引：0
|
作者：
Roose, Heleen [1 ]
Zhang, Qingling [2 ]
Le, Kha [2 ]
Jekle, Andreas [2 ]
Rekstyte-Matiene, Kristina [1 ]
Stevens, Sarah [2 ]
Jaisinghani, Ruchika [2 ]
Liu, Cheng [2 ]
Chang, Sandra [2 ]
Stoycheva, Antitsa [2 ]
Blatt, Lawrence [2 ]
Beigelman, Leonid [2 ]
Symons, Julian [2 ]
Chanda, Sushmita [2 ]
Gonzalvez, Francois [1 ]
Wu, Tongfei [1 ]
机构：
[1] Aligos Belgium Bv, Leuven, Belgium
[2] Aligos Therapeut Inc, San Francisco, CA USA
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-241
引用
收藏
页码：S1030 / S1031
页数：2
相关论文
共 18 条
  • [1] Preclinical pharmacokinetic/pharmacodynamic/efficacy relationships for alisertib, an investigational small-molecule inhibitor of Aurora A kinase
    Santhosh Palani
    Mayankbhai Patel
    Jessica Huck
    Mengkun Zhang
    Suresh K. Balani
    Johnny Yang
    Susan Chen
    Jerome Mettetal
    Mark Manfredi
    Wen Chyi Shyu
    Jeffrey A. Ecsedy
    Arijit Chakravarty
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 1255 - 1264
  • [2] Preclinical pharmacokinetic/pharmacodynamic/efficacy relationships for alisertib, an investigational small-molecule inhibitor of Aurora A kinase
    Palani, Santhosh
    Patel, Mayankbhai
    Huck, Jessica
    Zhang, Mengkun
    Balani, Suresh K.
    Yang, Johnny
    Chen, Susan
    Mettetal, Jerome
    Manfredi, Mark
    Shyu, Wen Chyi
    Ecsedy, Jeffrey A.
    Chakravarty, Arijit
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (06) : 1255 - 1264
  • [3] Pharmacokinetic/pharmacodynamic (PK/PD) relationships for the angiogenesis inhibitor ABT-510 in preclinical efficacy models
    Carr, R
    Marsh, K
    Schneider, A
    Henkin, J
    Wang, Y
    Joseph, I
    Khanna, C
    Humerickhouse, R
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S79 - S79
  • [4] DISCOVERY OF A LIVER TARGETED ORAL PD-L1 SMALL MOLECULE INHIBITOR FOR THE TREATMENT OF CHRONIC HEPATITIS B AND LIVER CANCER
    Roose, Heleen
    Rekstyte-Matiene, Kristina
    Stevens, Sarah K.
    Gupta, Kusum
    Chang, Sandra
    Liu, Cheng
    Serebryany, Vladimir
    Adame, Lillian
    Le, Kha
    Stoycheva, Antitsa
    Blatt, Lawrence M.
    Beigelman, Leonid N.
    Chanda, Sushmita
    Smith, David B.
    Symons, Julian
    Jekle, Andreas
    Wu, Tongfei
    HEPATOLOGY, 2023, 78 : S566 - S567
  • [5] Discovery of a novel, potent and selective small-molecule inhibitor of PD-1/PD-L1 interaction with robust in vivo anti-tumour efficacy
    Liu, Chenglong
    Zhou, Feilong
    Yan, Ziqin
    Shen, Lian
    Zhang, Xichen
    He, Fenglian
    Wang, Heng
    Lu, Xiaojie
    Yu, Ker
    Zhao, Yujun
    Zhu, Di
    BRITISH JOURNAL OF PHARMACOLOGY, 2021, 178 (13) : 2651 - 2670
  • [6] In vivo antitumor efficacy evaluation of ASC63, an oral small molecule PD-L1 inhibitor, in a humanized mouse tumor model
    Wu, Jinzi J.
    He, Handan
    CANCER RESEARCH, 2023, 83 (07)
  • [7] THE SMALL MOLECULE PD-L1 INHIBITOR CCX559 PREFERENTIALLY ACCUMULATES IN TUMORS, RESULTING IN DEPLETION OF CELL-SURFACE PD-L1 IN A MURINE PRECLINICAL MODEL
    Sullivan, Kathleen
    Ertl, Linda
    Miao, Zhenhua
    Fan, Pingchen
    Zeng, Yibin
    Dunlap, Carolyn
    Ebsworth, Karen
    Gupta, Suprit
    Li, Shijie Chris
    Dang, Ton
    Miao, Shichang
    Charo, Israel
    Schall, Thomas
    Zhang, Penglie
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A520 - A520
  • [8] A small molecule human PD-1/PD-L1 inhibitor promotes T cell immune activation and reduces tumor growth in a preclinical model
    Colomer, M. Vilalta
    Punna, S.
    Li, S.
    Malathong, V.
    Lange, C.
    McMurtrie, D.
    Yang, J.
    Roth, H.
    McMahon, J.
    Campbell, J. J.
    Ertl, L. S.
    Ong, R.
    Wang, Y.
    Zhao, N.
    Yau, S.
    Dang, T.
    Zhang, P.
    Schall, T. J.
    Singh, R.
    ANNALS OF ONCOLOGY, 2018, 29
  • [9] ORAL SMALL-MOLECULE LIVER-TROPIC PD-L1 INHIBITOR PHARMACOKINETICS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA
    Mondal, Arpita
    Thi, Emily P.
    Graves, Ingrid
    Heffernan, Gavin
    Xu, Fran
    Ozturk, Seyma
    Pohl, Amanda
    Fan, Kristi Y.
    Cole, Andrew
    Harasym, Troy
    Lam, Angela M.
    Sofia, Michael J.
    HEPATOLOGY, 2023, 78 : S1946 - S1947
  • [10] A potent and selective small molecule antagonist of PD-L1 ABSK043 demonstrates significantanti-tumor efficacy in combination with other agents in preclinical models
    Ying, Haiyan
    Zhang, Yongxian
    Yang, Fei
    Xin, Wenqun
    Song, Jiaqi
    Chen, Zhui
    CANCER RESEARCH, 2022, 82 (12)
12